The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting
- 31 October 2007
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 154 (4), 676-681
- https://doi.org/10.1016/j.ahj.2007.06.013
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: A 6 months prospective studyThrombosis Research, 2006
- Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2005
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJournal of the American College of Cardiology, 2004
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Profile and prevalence of aspirin resistance in patients with cardiovascular diseaseThe American Journal of Cardiology, 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001
- Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac EventsCirculation, 2001
- Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patientsThrombosis Research, 1993